I B Hirsch

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi Clinical review: Realistic expectations and practical use of continuous glucose monitoring for the endocrinologist
    Irl B Hirsch
    University of Washington School of Medicine, Seattle, Washington 98105, USA
    J Clin Endocrinol Metab 94:2232-8. 2009
  2. ncbi New insulin infusion protocol Improves blood glucose control in hospitalized patients without increasing hypoglycemia
    Susanna Y Ku
    University of Washington Medical Center, USA
    Jt Comm J Qual Patient Saf 31:141-7. 2005
  3. ncbi Insulin Degludec/Insulin Aspart Administered Once Daily at Any Meal, With Insulin Aspart at Other Meals Versus a Standard Basal-Bolus Regimen in Patients With Type 1 Diabetes: A 26-week, phase 3, randomized, open-label, treat-to-target trial
    Irl B Hirsch
    Corresponding author Irl B Hirsch
    Diabetes Care 35:2174-81. 2012
  4. ncbi Hyperthyroidism from autoimmune thyroiditis in a man with type 1 diabetes mellitus: a case report
    John K Amory
    Division of General Internal Medicine, Department of Medicine, University of Washington School of Medicine, 1959 NE Pacific Street, Seattle, WA 98195, USA
    J Med Case Reports 5:277. 2011
  5. ncbi Surveillance for complications of diabetes: don't wait for symptoms before intervening
    I B Hirsch
    Diabetes Care Center, University of Washington Medical Center, Seattle, 98195 6176, USA
    Postgrad Med 99:147-55, 159-62. 1996
  6. ncbi Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study
    Irl B Hirsch
    University of Washington Medical Center Roosevelt, Seattle, Washington 98105, USA
    Diabetes Technol Ther 10:377-83. 2008
  7. ncbi Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM)
    Irl B Hirsch
    Department of Medicine, University of Washington Medical Center Roosevelt, Seattle, Washington 98105, USA
    Diabetes Technol Ther 10:232-44; quiz 245-6. 2008
  8. ncbi Piecing the puzzle together: ACCORDing to whom?
    Irl B Hirsch
    University of Washington School of Medicine Roosevelt, 4225 Roosevelt Avenue Northeast, Suite 101, Seattle, Washington 98105, USA
    J Clin Endocrinol Metab 93:1161-3. 2008
  9. ncbi The changing faces of diabetes
    Irl B Hirsch
    Department of Medicine, University of Washington, 1959 NE Pacific Street, Box 356176, Seattle, WA 98195 6176, USA
    Prim Care 30:499-510. 2003
  10. ncbi Arguments against the use of inhaled insulin
    Irl B Hirsch
    University of Washington School of Medicine, Seattle, Washington 98105, USA
    Diabetes Technol Ther 9:S111-4. 2007

Detail Information

Publications77

  1. ncbi Clinical review: Realistic expectations and practical use of continuous glucose monitoring for the endocrinologist
    Irl B Hirsch
    University of Washington School of Medicine, Seattle, Washington 98105, USA
    J Clin Endocrinol Metab 94:2232-8. 2009
    ..Real-time continuous glucose monitoring (CGM) has been available for type 1 diabetes for several years. This paper is a status report on our early experiences with this next technology...
  2. ncbi New insulin infusion protocol Improves blood glucose control in hospitalized patients without increasing hypoglycemia
    Susanna Y Ku
    University of Washington Medical Center, USA
    Jt Comm J Qual Patient Saf 31:141-7. 2005
    ..In addition, there was no increase in hypoglycemia despite the use of the protocol in non-critical care units with higher patient-to-nurse ratios, suggests that insulin infusion therapy can be safely used outside of critical care units...
  3. ncbi Insulin Degludec/Insulin Aspart Administered Once Daily at Any Meal, With Insulin Aspart at Other Meals Versus a Standard Basal-Bolus Regimen in Patients With Type 1 Diabetes: A 26-week, phase 3, randomized, open-label, treat-to-target trial
    Irl B Hirsch
    Corresponding author Irl B Hirsch
    Diabetes Care 35:2174-81. 2012
    ....
  4. ncbi Hyperthyroidism from autoimmune thyroiditis in a man with type 1 diabetes mellitus: a case report
    John K Amory
    Division of General Internal Medicine, Department of Medicine, University of Washington School of Medicine, 1959 NE Pacific Street, Seattle, WA 98195, USA
    J Med Case Reports 5:277. 2011
    ..abstract:..
  5. ncbi Surveillance for complications of diabetes: don't wait for symptoms before intervening
    I B Hirsch
    Diabetes Care Center, University of Washington Medical Center, Seattle, 98195 6176, USA
    Postgrad Med 99:147-55, 159-62. 1996
    ..Early diagnosis and treatment often improve outcome and should dramatically decrease the burden of diabetes in our society...
  6. ncbi Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study
    Irl B Hirsch
    University of Washington Medical Center Roosevelt, Seattle, Washington 98105, USA
    Diabetes Technol Ther 10:377-83. 2008
    ....
  7. ncbi Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM)
    Irl B Hirsch
    Department of Medicine, University of Washington Medical Center Roosevelt, Seattle, Washington 98105, USA
    Diabetes Technol Ther 10:232-44; quiz 245-6. 2008
    ..Finally, researchers, manufacturers, payers, and advocacy groups must join forces on the policy level to create an environment conducive to managing continuous data, measuring outcomes, and formalizing best practices...
  8. ncbi Piecing the puzzle together: ACCORDing to whom?
    Irl B Hirsch
    University of Washington School of Medicine Roosevelt, 4225 Roosevelt Avenue Northeast, Suite 101, Seattle, Washington 98105, USA
    J Clin Endocrinol Metab 93:1161-3. 2008
  9. ncbi The changing faces of diabetes
    Irl B Hirsch
    Department of Medicine, University of Washington, 1959 NE Pacific Street, Box 356176, Seattle, WA 98195 6176, USA
    Prim Care 30:499-510. 2003
    ..Clearly, new classifications will be required as we learn more about the different types of diabetes...
  10. ncbi Arguments against the use of inhaled insulin
    Irl B Hirsch
    University of Washington School of Medicine, Seattle, Washington 98105, USA
    Diabetes Technol Ther 9:S111-4. 2007
  11. ncbi Glycemic variability: it's not just about A1C anymore!
    Irl B Hirsch
    University of Washington Medical Center, Seattle, Washington 98105, USA
    Diabetes Technol Ther 7:780-3. 2005
  12. ncbi Should minimal blood glucose variability become the gold standard of glycemic control?
    Irl B Hirsch
    University of Washington Medical Center, Box 356176, 1959 NE Pacific Street, PO Seattle, WA 98105 6176, United States
    J Diabetes Complications 19:178-81. 2005
    ....
  13. ncbi Intensifying insulin therapy in patients with type 2 diabetes mellitus
    Irl B Hirsch
    Diabetes Care Center, Division of Endocrinology, University of Washington School of Medicine, Seattle, Washington 98195, USA
    Am J Med 118:21S-6S. 2005
    ....
  14. ncbi Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII
    Irl B Hirsch
    University of Washington, Seattle, WA, USA
    Diabetes Care 28:533-8. 2005
    ..Multiple daily injection (MDI) therapy of bolus insulin aspart and basal insulin glargine was compared with continuous subcutaneous insulin infusion (CSII) with aspart in type 1 diabetic patients previously treated with CSII...
  15. ncbi The burden of diabetes (care)
    Irl B Hirsch
    Department of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, USA
    Diabetes Care 26:1613-4. 2003
  16. ncbi Insulin analogues
    Irl B Hirsch
    Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195-6176, USA
    N Engl J Med 352:174-83. 2005
  17. ncbi Patient factors associated with glucagonlike peptide 1 receptor agonist use with and without insulin
    Irl B Hirsch
    University of Washington School of Medicine, Seattle, Washington, USA
    Endocr Pract 17:707-16. 2011
    ..To evaluate both the patient factors associated with the initiation of exenatide and the real-world treatment patterns of exenatide use with and without insulin...
  18. ncbi A multifaceted intervention in support of diabetes treatment guidelines: a cont trial
    Irl B Hirsch
    Division of Metabolism, Endocrinology and Nutrition, University of Washington School of Medicine, 1959 NE Pacific Street, Box 356176, Seattle, WA 98195, USA
    Diabetes Res Clin Pract 58:27-36. 2002
    ..Providers received didactic training and computerized compliance feedback to support staged diabetes management, an evidenced-based approach to diabetes care...
  19. ncbi Practical pearls in insulin pump therapy
    Irl B Hirsch
    University of Washington School of Medicine, Medical Center, 4225 Roosevelt Way NE, Seattle, WA 98101, USA
    Diabetes Technol Ther 12:S23-7. 2010
    ..Finally, the introduction of bolus calculators and software to download the pumps has provided technology that when used appropriately can further benefit glycemic control...
  20. ncbi Impact of prandial plus basal vs basal insulin on glycemic variability in type 2 diabetic patients
    Irl B Hirsch
    University of Washington Medical Center Roosevelt, 4225 Roosevelt Way NE, Ste 101 Box 354691, Seattle, WA 98105, USA
    Endocr Pract 15:343-8. 2009
    ....
  21. ncbi Web-based collaborative care for type 2 diabetes: a pilot randomized trial
    James D Ralston
    Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA
    Diabetes Care 32:234-9. 2009
    ..To test Web-based care management of glycemic control using a shared electronic medical record with patients who have type 2 diabetes...
  22. ncbi Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review
    Dawn E DeWitt
    Division of General Internal Medicine, Department of Medicine, University of Washington, Seattle, USA
    JAMA 289:2254-64. 2003
    ..The key to effective insulin therapy is an understanding of principles that, when implemented, can result in improved diabetes control...
  23. ncbi Individualizing care for the many: the evolving role of professional continuous glucose monitoring systems in clinical practice
    Elizabeth A Nardacci
    Albany Medical Center, Division of Endocrinology, Albany, NY 12208, USA
    Diabetes Educ 36:4S-19S; quiz 20S-21S. 2010
    ..CONCLUSION: Strategic implementation of professional CGM may improve the time- and cost-effectiveness of diabetes care while advancing more personalized treatment in the course of everyday practice...
  24. ncbi Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes
    R Juneja
    Department of Medicine, University of Washington, Seattle, WA 98108, USA
    Metabolism 50:1008-13. 2001
    ..We therefore conclude that screening with antibodies, mainly ICA and GAD, but not age, BMI, or clinical presentation should be used to identify type 1(1/2) diabetes...
  25. ncbi Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes
    R E Ratner
    MedStar Clinical Research Center, Washington, DC, USA
    Diabetes Care 23:639-43. 2000
    ..This study compared insulin glargine with NPH human insulin in subjects with type 1 diabetes who had been previously treated with multiple daily injections of NPH insulin and regular insulin...
  26. ncbi Improving the quality of outpatient care for older patients with diabetes: lessons from a comparison of rural and urban communities
    R A Rosenblatt
    University of Washington, Department of Family Medicine, Box 354696, Seattle, WA 98195 4696, USA
    J Fam Pract 50:676-80. 2001
    ..Our goal was to compare the quality of diabetic care received by patients in rural and urban communities...
  27. ncbi A path model of chronic stress, the metabolic syndrome, and coronary heart disease
    Peter P Vitaliano
    Departments of Psychiatry and Behavioral Sciences and Medicine, University of Washington, Seattle, Washington 98195 6560, USA
    Psychosom Med 64:418-35. 2002
    ....
  28. ncbi Interpersonal predictors of HbA(1c) in patients with type 1 diabetes
    Paul S Ciechanowski
    Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington 98195, USA
    Diabetes Care 25:731-6. 2002
    ....
  29. ncbi Inpatient diabetes: review of data from the cardiac care unit
    Irl B Hirsch
    Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington School of Medicine, Seattle, Washington, USA
    Endocr Pract 12:27-34. 2006
    ..While we improve our understanding of the basic roles of glucose and insulin in modulating inflammation, we must aggressively treat hyperglycemia to the national goals for this population, which would substantially improve outcomes...
  30. ncbi The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes
    Paul S Ciechanowski
    Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA 98195, USA
    Gen Hosp Psychiatry 25:246-52. 2003
    ..Because of their association with clinical aspects of diabetes care such as diabetes symptom reporting and adherence to diabetes self-care, depressive symptoms are important to recognize in treating patients with diabetes...
  31. ncbi Designing mobile support for glycemic control in patients with diabetes
    Lynne T Harris
    Department of Health Services, University of Washington, Magnuson Health Sciences Center, Room H 664, Seattle, WA 98195 7660, USA
    J Biomed Inform 43:S37-40. 2010
    ..Participants saw value in the mobile system as an adjunct to the Web-based program and traditional office-based care. Mobile diabetes management systems may represent one strategy to improve the quality of diabetes care...
  32. ncbi Practical aspects of real-time continuous glucose monitoring
    Lisa K Gilliam
    University of Washington Medical Center, Seattle, Washington 98195 7710, USA
    Diabetes Technol Ther 11:S75-82. 2009
    ..In this review, we will discuss the practical benefits and challenges of rt-CGM use, in order to better educate care providers as to which of their patients might actually benefit from this technology...
  33. ncbi Web-based collaborative care for type 1 diabetes: a pilot randomized trial
    Kelly P McCarrier
    Department of Health Services, University of Washington, Seattle, Washington 98195, USA
    Diabetes Technol Ther 11:211-7. 2009
    ....
  34. ncbi Assessment of therapy with continuous subcutaneous insulin infusion in an academic diabetes clinic
    Justen W Rudolph
    Department of Medicine, Division of Metabolism, Endocrinology, and Nutrition, University of Washington School of Medicine, Seattle, Washington, USA
    Endocr Pract 8:401-5. 2002
    ..CSII therapy, when provided in conjunction with a standard educational program, should continue to be an important treatment option in appropriately selected patients with type 1 diabetes...
  35. ncbi Using an Internet comanagement module to improve the quality of chronic disease care
    Harold I Goldberg
    University of Washington, Seattle, USA
    Jt Comm J Qual Saf 29:443-51. 2003
    ..At the University of Washington, a diabetes care module was developed, and the feasibility of allowing patients with type 2 diabetes to comanage their disease from home was pilot tested...
  36. ncbi Blood glucose monitoring technology: translating data into practice
    Irl B Hirsch
    The University of Washington Medical Center, Seattle, Washington, USA
    Endocr Pract 10:67-76. 2004
    ..CONCLUSION: Data downloaded from glucose meters can be used in conjunction with written records in logbooks to evaluate glucose patterns and formulate more precise and efficacious therapeutic regimens...
  37. ncbi Evidence-based management: using serial firm trials to improve diabetes care quality
    Harold I Goldberg
    University of Washington, Seattle, USA
    Jt Comm J Qual Improv 28:155-66. 2002
    ..The effectiveness of the "computerized firm system" approach to chronic disease CQI was examined, with diabetes as the focus of a 5-year case study...
  38. ncbi Self-Monitoring of Blood Glucose (SMBG) in insulin- and non-insulin-using adults with diabetes: consensus recommendations for improving SMBG accuracy, utilization, and research
    Irl B Hirsch
    Department of Medicine, University of Washington Medical Center Roosevelt, Seattle, Washington 98105, USA
    Diabetes Technol Ther 10:419-39. 2008
    ..The panel also made suggestions for designing future studies that increase the ability to discern optimal models of SMBG utilization for individuals with diabetes who may, or may not, use insulin...
  39. ncbi The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change
    Dace L Trence
    Division of Metabolism, Endocrinology, and Nutrition, University of Washington School of Medicine, Seattle, Washington 98195-6176, USA
    J Clin Endocrinol Metab 88:2430-7. 2003
    ..v. and s.c. insulin. Although there are several appropriate options for both of these routes of administration, it is critical that all caregivers involved in this population's care are knowledgeable about insulin strategies...
  40. ncbi Use of serum and plasma glucose measurements as a benchmark for improved hospital-wide glycemic control
    Andrew N Hoofnagle
    Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA
    Endocr Pract 14:556-63. 2008
    ..To demonstrate the benefit of an institutionally implemented glucose control intervention based on serum and plasma glucose values in the acute inpatient setting...
  41. ncbi Animal insulin therapy induces a biased insulin antibody response that persists for years after introduction of human insulin
    Shilpa Oak
    Department of Medicine, University of Washington, Seattle, WA, USA
    Acta Diabetol 47:131-5. 2010
    ..0001). We conclude that IA binding level and epitope specificity are biased by treatment with animal insulin. This bias remains for over 20 years after animal insulin treatment is terminated...
  42. ncbi Sepsis and glycemia: read the fine print!
    Irl B Hirsch
    Division of Metabolism, Endocrinology and Nutrition, University of Washington School of Medicine, Seattle, Washington 98195-4691, USA
    Endocr Pract 14:389-90. 2008
  43. ncbi Implementing an intravenous insulin protocol in your practice: practical advice to overcome clinical, administrative, and financial barriers
    Janet L Kelly
    University of Washington Medical Center, School of Pharmacy, Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA, USA
    Semin Thorac Cardiovasc Surg 18:346-58. 2006
    ....
  44. ncbi Optimal initiation of insulin in type 2 diabetes
    Irl B Hirsch
    University of Washington, University of Washington Medical Center, Seattle, Washington, USA
    MedGenMed 7:49. 2005
    ..In addition to A1C, a patient's age, lifestyle, competence, personal preferences, and comorbidities can be used to help determine the choice of insulin therapy...
  45. ncbi Treatment of patients with severe insulin deficiency; what we have learned over the past 2 years
    Irl B Hirsch
    Diabetes Care Center and the Department of Medicine, University of Washington School of Medicine, 1959 NE Pacific, UW Mailbox 356176, Seattle, WA 98195-6176, USA
    Am J Med 116:17S-22S. 2004
    ..Newer insulin analogues, improved devices for home glucose monitoring, and pulmonary inhaled insulin are other innovations that promise improvement of hemoglobin A(1c) levels...
  46. ncbi Hyperglycemic crises in diabetes mellitus type 2
    D L Trence
    Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA
    Endocrinol Metab Clin North Am 30:817-31. 2001
    ..Medications such as the protease inhibitors may in the future lead to a better understanding of the pathophysiology of the metabolic derangements seen in the development of type 2 diabetes mellitus...
  47. ncbi The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients
    Marilyn J Hammer
    Department of Biobehavioral Nursing and Health Systems, University of Washington, Seattle, Washington, USA
    Biol Blood Marrow Transplant 15:344-51. 2009
    ..The applicability of these findings to other situations and whether correcting malglycemia in HCT can lead to reductions in mortality remain to be determined...
  48. ncbi Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial
    Jonathan Q Purnell
    Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health and Science University, Portland, Oregon 97201, USA
    Diabetes 52:2623-9. 2003
    ..These data support the hypothesis that increased weight gain with intensive therapy might be explained, in part, by genetic traits...
  49. ncbi Inpatient management of adults and children with type 1 diabetes
    David M Tridgell
    Division of Metabolism, Endocrinology and Nutrition, University of Washington, 1959 NE Pacific Street, Box 356426, Seattle, WA 98195, USA
    Endocrinol Metab Clin North Am 39:595-608. 2010
    ..This article focuses on inpatient and perioperative insulin management of stable, nonketotic, nonpregnant adults and children with type 1 diabetes. These principles can also be applied to patients with steroid-induced hyperglycemia...
  50. ncbi Isn't this just bedtime snacking? The potential adverse effects of night-eating symptoms on treatment adherence and outcomes in patients with diabetes
    Shereen A Morse
    Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98195 6560, USA
    Diabetes Care 29:1800-4. 2006
    ..Psychosocial variables and emotional triggers may be associated with these behaviors. In patients with diabetes, such behaviors may lead to glucose dysregulation and contribute to obesity and complications...
  51. ncbi Effect of insulin therapy on nonglycemic variables during acute illness
    Irl B Hirsch
    University of Washington School of Medicine, Seattle, Washington, USA
    Endocr Pract 10:63-70. 2004
    ....
  52. ncbi American College of Endocrinology position statement on inpatient diabetes and metabolic control
    Alan J Garber
    Endocr Pract 10:4-9. 2004
  53. ncbi Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes
    Shalamar D Sibley
    Division of Endocrinology and Diabetes, University of Minnesota, Minneapolis, Minnesota 55455, USA
    J Clin Endocrinol Metab 88:3379-84. 2003
    ..DCCT-related weight gain positively correlated with subsequent IAF...
  54. ncbi Intensive insulin therapy in critically ill patients
    Irl B Hirsch
    N Engl J Med 346:1586-8; author reply 1586-8. 2002
  55. ncbi Depression-related hyperglycemia in type 1 diabetes: a mediational approach
    Patrick J Lustman
    Department of Psychiatry, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, MO 63110, USA
    Psychosom Med 67:195-9. 2005
    ..In this study, we applied mediational analysis methods to determine whether the hyperglycemic effect of depression could be mediated by poor diabetes self-care...
  56. ncbi American College of Endocrinology position statement on inpatient diabetes and metabolic control
    Alan J Garber
    Endocr Pract 10:77-82. 2004
  57. ncbi Hospital management of diabetes
    Etie S Moghissi
    Inpatient Diabetes and Metabolic Control Task Force, American Association of Clinical Endocrinologists, 501 East Hardy Street, Suite 110, Inglewood, CA 90301, USA
    Endocrinol Metab Clin North Am 34:99-116. 2005
    ..We believe that we can already state with confidence that the preliminary evidence shows that, like outpatient diabetes management,metabolic control matters during acute illness...
  58. ncbi Novel insulins and strict glycemic control. Analogues approximate normal insulin secretory response
    John R White
    Department of Pharmacotherapy, Washington State University College of Pharmacy, Spokane, WA 99210 1495, USA
    Postgrad Med 113:30-6. 2003
    ..In this article, the authors review the development of insulin formulations and the pharmacology of currently available insulin molecules and those soon to be on the market...
  59. ncbi Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes
    Lawrence Blonde
    Diabetes Care 25:245-6. 2002
  60. ncbi Continuous glucose monitoring and intensive treatment of type 1 diabetes
    William V Tamborlane
    N Engl J Med 359:1464-76. 2008
    ..Further work is needed to identify barriers to effectiveness of continuous monitoring in children and adolescents. (ClinicalTrials.gov number, NCT00406133.)..
  61. ncbi The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes
    John Mastrototaro
    Medtronic Diabetes, Northridge, California 91325 1219, USA
    Diabetes Technol Ther 10:385-90. 2008
    ..The accuracy and efficacy of the Medtronic Diabetes (Northridge, CA) Real-Time (RT)-Continuous Glucose Monitoring (CGM) sensor were analyzed in 72 subjects with type 1 diabetes...
  62. ncbi Insulin therapy for type 2 diabetes. Getting started
    Christin Snyder
    Diabetes Self Manag 25:30, 32-3, 35-6. 2008
  63. ncbi Fighting diabetic kidney disease. The best defense is a good offense--take action now to prevent kidney disease
    Irl B Hirsch
    Diabetes Forecast 55:68-70. 2002
  64. ncbi Evidence-based priming
    Irl B Hirsch
    Diabetes Technol Ther 8:521-2. 2006
  65. ncbi Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes
    Monique M Williams
    Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Diabetes Care 30:801-6. 2007
    ..A secondary analysis was performed to assess this effect in younger and older subsets of patients...
  66. ncbi Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications
    Michael Brownlee
    JAMA 295:1707-8. 2006
  67. ncbi Pharmacotherapies for diabetes management: an update for the practicing clinician
    Luigi Meneghini
    University of Miami Miller School of Medicine, Diabetes Research Institute, Miami, Florida 33136, USA
    Semin Thorac Cardiovasc Surg 18:379-89. 2006
    ....
  68. ncbi Insulin therapy: evolution and practice
    Irl B Hirsch
    Endocrinol Metab Clin North Am 36:7-8. 2007
  69. ncbi Self-monitoring of blood glucose cannot compensate for ineffective diabetes management
    Christopher G Parkin
    Am J Med 118:1448; author reply 1448-9. 2005
  70. ncbi Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study
    Philip Raskin
    University of Texas, Southwestern Medical Center, Dallas, Texas 75390 8858, USA
    Diabetes Care 26:2598-603. 2003
    ..Compare the efficacy, safety, and patient satisfaction of continuous subcutaneous insulin infusion (CSII) therapy with multiple daily injection (MDI) therapy for patients with type 2 diabetes...
  71. ncbi Type 2 diabetes: the role of basal insulin therapy
    Derek LeRoith
    J Fam Pract 53:215-22. 2004
  72. ncbi Management of diabetes and hyperglycemia in hospitals
    Stephen Clement
    Department of Endocrinology, Georgetown University Hospital, Washington, DC 20007, USA
    Diabetes Care 27:553-91. 2004
  73. ncbi Diabetes and heart failure: is insulin therapy the answer?
    Wayne C Levy
    J Am Coll Cardiol 42:1051-3. 2003
  74. ncbi In-patient hyperglycemia--are we ready to treat it yet?
    Irl B Hirsch
    J Clin Endocrinol Metab 87:975-7. 2002
  75. ncbi The effect of glucose variability on the risk of microvascular complications in type 1 diabetes
    Irl B Hirsch
    Diabetes Care 30:186-7; author reply 188-9. 2007
  76. ncbi What's in a name: latent autoimmune diabetes of adults, type 1.5, adult-onset, and type 1 diabetes
    Jerry P Palmer
    Diabetes Care 26:536-8. 2003
  77. ncbi Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial
    Patrick J Lustman
    Department of Veterans Affairs Medical Center, St Louis, MO, USA
    Arch Gen Psychiatry 63:521-9. 2006
    ..In patients with diabetes mellitus, depression is a prevalent and recurrent problem that adversely affects the medical prognosis...